Evidence map›Paper›PMID 28290048›Full record

ArticleMolecular and cellular biochemistry2017

Carnosine modulates nitric oxide in stimulated murine RAW 264.7 macrophages.

Giuseppe Caruso, Claudia G Fresta, Francisco Martinez-Becerra, Lopalco Antonio, Ryan T Johnson, Richard P S de Campos, Joseph M Siegel, Manjula B Wijesinghe, Giuseppe Lazzarino, Susan M Lunte

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Comparative urinary metabolomics reveals unique and shared pathways in COVID-19 and liver diseases.Metabolomics : Official journal of the Metabolomic Society · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Histidine-Containing Dipeptides in Obesity and Cardiometabolic Health: A Systematic Scoping Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Giuseppe CarusoRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS, USA.
Claudia G FrestaRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS, USA.
Francisco Martinez-BecerraDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA.
Lopalco AntonioDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA.
Ryan T JohnsonDepartment of Chemistry, University of Kansas, Lawrence, KS, USA.
Richard P S de CamposRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS, USA.
Joseph M SiegelRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS, USA.
Manjula B WijesingheRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS, USA.
Giuseppe LazzarinoDivision of Medical Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy. lazzarig@unict.it.
Susan M LunteRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS, USA. slunte@ku.edu.
University of Kansas · USUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Catania · IT

Funding

Understanding the mechanobiology of stem cells in a microengineered 3D cardiac tissue environment with cardiomyopathyP20GM103638 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI LUNTE, SUSAN M · 2012 to 2021
$22.1M
Analytical Methods for Investigating Peptide TransportR01NS042929 · NINDS · UNIVERSITY OF KANSAS LAWRENCE · PI LUNTE, SUSAN M · 2002 to 2011
$2.3M
NIGMS NIH HHS P20 GM103638NINDS NIH HHS R01 NS042929
6 · The paper itself

Abstract

Excess nitric oxide (NO) production occurs in several pathological states, including neurodegeneration, ischemia, and inflammation, and is generally accompanied by increased oxidative/nitrosative stress. Carnosine [β-alanine-histidine (β-Ala-His)] has been reported to decrease oxidative/nitrosative stress-associated cell damage by reducing the amount of NO produced. In this study, we evaluated the effect of carnosine on NO production by murine RAW 264.7 macrophages stimulated with lipopolysaccharides + interferon-γ. Intracellular NO and intracellular and extracellular nitrite were measured by microchip electrophoresis with laser-induced fluorescence and by the Griess assay, respectively. Results showed that carnosine causes an apparent suppression of total NO production by stimulated macrophages accompanied by an unexpected simultaneous drastic increase in its intracellular low toxicity endproduct, nitrite, with no inhibition of inducible nitric oxide synthase (iNOS). ESI-MS and NMR spectroscopy in a cell-free system showed the formation of multiple adducts (at different ratios) of carnosine-NO and carnosine-nitrite, involving both constituent amino acids (β-Ala and His) of carnosine, thus providing a possible mechanism for the changes in free NO and nitrite in the presence of carnosine. In stimulated macrophages, the addition of carnosine was also characterized by changes in the expression of macrophage activation markers and a decrease in the release of IL-6, suggesting that carnosine might alter M1/M2 macrophage ratio. These results provide evidence for previously unknown properties of carnosine that modulate the NO/nitrite ratio of stimulated macrophages. This modulation is also accompanied by changes in the release of pro-inflammatory molecules, and does not involve the inhibition of iNOS activity.

Indexed as

AnimalsCarnosineInterferon-gammaInterleukin-6LipopolysaccharidesMacrophage ActivationMacrophagesMiceNitric OxideNitric Oxide Synthase Type IIRAW 264.7 CellsCarnosineIFNG protein, mouseInterferon-gammaInterleukin-6interleukin-6, mouseLipopolysaccharidesNitric OxideNitric Oxide Synthase Type IINos2 protein, mouseCarnosineCytokines secretionMacrophagesMicrochip electrophoresisNitric oxideNitrite

Identifiers

PMID28290048
PMCPMC5697141
OpenAlexW2596463029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.